Switch theme
Sign up to access all valuation multiples
Judges Scientific PLC is engaged in the designing, manufacturing, and sale of scientific instruments. The company operates in two main segments namely Materials Sciences and Vacuum. The firm specializes in the acquisition and development of a portfolio of scientific instrument businesses. The company has operational footprints across the United Kingdom, the Rest of Europe, North America, and the Rest of the world.
2002
777
LTM Revenue $188M
LTM EBITDA $47.7M
$780M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Judges Scientific has a last 12-month revenue (LTM) of $188M and a last 12-month EBITDA of $47.7M.
In the most recent fiscal year, Judges Scientific achieved revenue of $179M and an EBITDA of $41.5M.
Judges Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Judges Scientific valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $188M | XXX | $179M | XXX | XXX | XXX |
| Gross Profit | $188M | XXX | $124M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 69% | XXX | XXX | XXX |
| EBITDA | $47.7M | XXX | $41.5M | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 23% | XXX | XXX | XXX |
| EBIT | $42.4M | XXX | $23.1M | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $25.1M | XXX | $14.0M | XXX | XXX | XXX |
| Net Margin | 13% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $66.7M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Judges Scientific's stock price is GBP 79 (or $106).
Judges Scientific has current market cap of GBP 525M (or $705M), and EV of GBP 581M (or $780M).
See Judges Scientific trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $780M | $705M | XXX | XXX | XXX | XXX | $4.25 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Judges Scientific has market cap of $705M and EV of $780M.
Judges Scientific's trades at 4.3x EV/Revenue multiple, and 18.8x EV/EBITDA.
Equity research analysts estimate Judges Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Judges Scientific has a P/E ratio of 28.1x.
See valuation multiples for Judges Scientific and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $705M | XXX | $705M | XXX | XXX | XXX |
| EV (current) | $780M | XXX | $780M | XXX | XXX | XXX |
| EV/Revenue | 4.1x | XXX | 4.3x | XXX | XXX | XXX |
| EV/EBITDA | 16.4x | XXX | 18.8x | XXX | XXX | XXX |
| EV/EBIT | 18.4x | XXX | 33.8x | XXX | XXX | XXX |
| EV/Gross Profit | 4.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 28.1x | XXX | 50.5x | XXX | XXX | XXX |
| EV/FCF | 31.1x | XXX | 26.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialJudges Scientific's last 12 month revenue growth is 9%
Judges Scientific's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Judges Scientific's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Judges Scientific's rule of X is 48% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Judges Scientific and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | 36% | XXX | 32% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 48% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 56% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Catapult | XXX | XXX | XXX | XXX | XXX | XXX |
| Optiscan Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| NanoFocus | XXX | XXX | XXX | XXX | XXX | XXX |
| Q-Interline | XXX | XXX | XXX | XXX | XXX | XXX |
| Jenoptik | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Judges Scientific acquired XXX companies to date.
Last acquisition by Judges Scientific was XXXXXXXX, XXXXX XXXXX XXXXXX . Judges Scientific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Judges Scientific founded? | Judges Scientific was founded in 2002. |
| Where is Judges Scientific headquartered? | Judges Scientific is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Judges Scientific have? | As of today, Judges Scientific has 777 employees. |
| Who is the CEO of Judges Scientific? | Judges Scientific's CEO is Mr. David Elie Cicurel. |
| Is Judges Scientific publicy listed? | Yes, Judges Scientific is a public company listed on LON. |
| What is the stock symbol of Judges Scientific? | Judges Scientific trades under JDG ticker. |
| When did Judges Scientific go public? | Judges Scientific went public in 2003. |
| Who are competitors of Judges Scientific? | Similar companies to Judges Scientific include e.g. Catapult, Optiscan Imaging, NanoFocus, Q-Interline. |
| What is the current market cap of Judges Scientific? | Judges Scientific's current market cap is $705M |
| What is the current revenue of Judges Scientific? | Judges Scientific's last 12 months revenue is $188M. |
| What is the current revenue growth of Judges Scientific? | Judges Scientific revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Judges Scientific? | Current revenue multiple of Judges Scientific is 4.1x. |
| Is Judges Scientific profitable? | Yes, Judges Scientific is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Judges Scientific? | Judges Scientific's last 12 months EBITDA is $47.7M. |
| What is Judges Scientific's EBITDA margin? | Judges Scientific's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Judges Scientific? | Current EBITDA multiple of Judges Scientific is 16.4x. |
| What is the current FCF of Judges Scientific? | Judges Scientific's last 12 months FCF is $25.1M. |
| What is Judges Scientific's FCF margin? | Judges Scientific's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Judges Scientific? | Current FCF multiple of Judges Scientific is 31.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
